<DOC>
	<DOC>NCT03050489</DOC>
	<brief_summary>Assessment of myocardial ischemic-reperfusion injury during off- and on- pump CABG.</brief_summary>
	<brief_title>Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG</brief_title>
	<detailed_description>Assessment of myocardial ischemic-reperfusion injury during off- and on- pump CABG is monitored by intraoperative measurement of serum level of myeloperoxidase before sternotomy and after sternal closure.</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Myocardial Reperfusion Injury</mesh_term>
	<criteria>ischemic heart disease valve disease diabetes millitus</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CABG</keyword>
	<keyword>Off-Pump CABG</keyword>
	<keyword>On-Pump CABG</keyword>
	<keyword>ischemic-reperfusion injury during CABG</keyword>
	<keyword>comparison of On- and Off- Pump CABG</keyword>
	<keyword>Ischemic Heart Disease</keyword>
	<keyword>Myocardial ischemia-reperfusion and myeloperoxidase</keyword>
	<keyword>Myocardial ischemia-reperfusion biomarkers</keyword>
</DOC>